ロード中...
Abciximab as a bridging strategy to overcome morphine–prasugrel interaction in STEMI patients
OBJECTIVE: The present study investigated whether the glycoprotein (GP)IIb/IIIa receptor blocker abciximab might be a successful bridging strategy to achieve adequate levels of platelet inhibition rapidly in cases where prasugrel is used in morphine‐pretreated ST‐elevation myocardial infarction (STE...
保存先:
| 出版年: | Br J Clin Pharmacol |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5061801/ https://ncbi.nlm.nih.gov/pubmed/27366874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13053 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|